Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

M3DICINE Introduces Stethee™, the World’s First AI-Enabled Stethoscope System
  • USA - English


News provided by

Jan 25, 2018, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Youtube
Youtube

BRISBANE, Australia and BOSTON (PRWEB) January 25, 2018 -- M3DICINE Inc, designers of intelligent medical devices, today announced the launch of Stethee, the world’s first AI-enabled stethoscope system. With a revolutionary new design that works as easily as a traditional stethoscope, the Stethee™ family of products allows users to listen to heart and lungs sounds with sophisticated amplification and filtering technology and to instantly capture and analyze heart and lung sounds and data via Bluetooth to the Stethee iOS or Android App providing a whole new level of diagnostics capabilities.

“This most iconic and enduring symbol of healthcare is now reinvented, into an intelligent and sophisticated medical device-- a powerful diagnostic assistant that becomes more intelligent the more it is used"

Post this

The Stethee system includes three core products: The FDA Cleared Stethee Pro for medical and healthcare professionals, Stethee Vet for veterinarians and animal professionals, and Stethee Edu developed specifically as an education and research tool.

The technology platform behind the Stethee AI engine, named “Aida,” can analyze heart and lung sounds to build a unique personal biometric signature. Aida also automatically tags geo-location and environmental data to each sample in real-time. This provides a completely new dimension of data analytics for public health planning allowing us to understand what effects environmental factors like humidity, temperature, pollen count or pollution have on our heart and lungs. Aida analyzes this encrypted and anonymized data in order learn and report back quantitative clinically actionable data to doctors, vets, and healthcare professionals.

“This most iconic and enduring symbol of healthcare is now reinvented, into an intelligent and sophisticated medical device-- a powerful diagnostic assistant that becomes more intelligent the more it is used,” said Nayyar Hussain, M.D., founder and CEO of M3DICINE. “The complementary Stethee Apps bring the power of machine learning and deep neural networks to health professionals worldwide who can use this data not only to monitor the progress and health of individual patients, but collectively to uncover new patterns and trends to help in the fight against heart and lung disease globally.”

“The potential for Stethee to be used in remote and rural areas is enormous because it’s incredibly easy to use and the results can be shared and analysed instantly by a medical specialist anywhere in the world,” said Hussain. “The ability to record, share and compare samples is invaluable to improving patient care, especially for remote and rural clinics where access to screening services or a cardiologist is extremely difficult.”

Stethee captures a wealth of rich clinical information in only 20 seconds. The sound and data from the device streams to any Bluetooth enabled device or wired headphones. Aida analyzes the signal to identify heart sounds and respiratory activity, as well as any patterns that might indicate a disease condition. The data is represented in real time in the Stethee App for easy understanding of vital signs, and can be easily shared with peers, caregivers or specialists anywhere in the world.

Since 2015 M3DICINE has worked closely with: designers and engineers from MIT (Massachusetts Institute of Technology), clinical experts from the Mayo Clinic, Texas A&M University and cardiologists, nurses and allied health professionals from the UK, Malaysia, Singapore and Australia. The entire development process of the Stethee System has adhered to the highest international design and safety standards and US FDA.

“The Stethee system has the potential to transform healthcare,” said Professor John Sperling, M.D., Vice-Chair, Department of Orthopedic Surgery MAYO Clinic said, "We are on the forefront of a new era in healthcare driven by artificial intelligence and its ability to significantly improve our ability to care for patients. This innovative technology can significantly help drive efficiency and productivity and empower healthcare providers worldwide by providing real time data and clinical interpretation.”

"Stethee Vet has enormous potential to assist our understanding of animal health," said Rosemary Booth, Wildlife Veterinarian and Director of Australia Zoo Wildlife Hospital. "Its geo-location functionality adds efficiency and detail for field researchers. Its small, sleek design doesn't alarm the animals, its sensitivity surpasses human senses and the AI 'learns' with increasing use."

M3DICINE has signed exclusive agreements with Korea Telecom for the distribution of Stethee Pro for telemedicine projects into a number of developing countries and an exclusive distribution agreement with Cargill Korea for Stethee Vet to veterinarians in South Korea.

Now available online for pre-order from stethee.com, units will begin shipping late February. Stethee Pro and Stethee Vet are available for $499. Stethee Edu for education and research will be available summer 2018. Advanced AI-driven analytics and insights are available through Stethee Central, a subscription based web portal. Stethee Pro and Stethee Vet App will be available for download from the Apple Store and Google Play store.

M3DICINE Pty Ltd is backed by an initial financing round of $4.5 million from private investors including Pond Capital and, more recently, the Board has approved the raise of a $2.5 million convertible note managed by Pond Capital. Funds from the new note will support product development, sales and marketing, as well as building out service capabilities. M3DICINE has research agreements with Sinskey Labs at MIT, Queensland University of Technology, University of Malaysia and professors and researchers at Texas A&M, Australia Zoo Hospital, University of Sydney, and Texas Heart and Mayo Clinic.

Social Links
Visit us on LinkedIn
Visit us on Twitter
Find us on Facebook
See us on YouTube

About M3DICINE
M3DICINE is a privately held medical device design and manufacturing company based in Brisbane Australia with U.S. offices in Boston, MA. At M3DICINE, our mission is to create beautifully designed, intelligent medical devices that capture powerful clinical data and empower health professionals and patients to understand health better. The first product is Stethee, the world’s first AI-enabled stethoscope system. For more information, visit http://www.stethee.com.

David Templeton, http://www.stethee.com, +1 (203) 530-0458, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.